Close
ACHEMA MIDDLE EAST 2026

Persistent Bacteria Are Undermining Antibiotic Treatment

Researchers from Uppsala University in Sweden have released a study on how various antibiotic treatments affect different types of bacteria and how they respond...

First Treatment For Advanced ASPS Is Given The Green Light

Atezolizumab (Tecentriq), a therapy for advanced alveolar soft tissue sarcoma (ASPS), has received FDA approval for the first time for adults and children two...

FDA Drug Nods In 2022 Fall To 37 From 51 Average Since 2017

The FDA recorded only 37 new drug approvals in 2022, down from an annual average of 51 since 2017. After having to retract its...

New Method Finds The Most Effective Cure For Breast Cancer

A technique created by Karolinska Institutet researchers should be able to forecast whether a breast cancer patient will benefit from a specific treatment or...

New Method May Stop Antibody From Rejecting Transplant Cells

Researchers at UCSF have developed a novel, potentially life-saving technique that may prevent antibodies from prompting the immune system to reject specifically tailored therapeutic...

Technology Advancement In The Biopharma Outsourcing Market

Due to the fact that many contract manufacturing organisations (CMOs) are the only facilities able to produce vaccines and treatments in the enormous volumes...

Global Alliance Finds Genetic Cause of Neurological Disease

The recognition of a previously unidentified genetic cause of late-onset cerebellar ataxia is reported in a new study that was released recently in the...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...